JAMES M FRATES, the Chief Financial Officer of $AMLX, sold 3,326 shares of the company on 01-06-2026 for an estimated $36,953. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.8% of their shares of this class of stock. Following this trade, they now own 177,104 shares of this class of $AMLX stock.
$AMLX Insider Trading Activity
$AMLX insiders have traded $AMLX stock on the open market 7 times in the past 6 months. Of those trades, 1 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $AMLX stock by insiders over the last 6 months:
- GINA MAZZARIELLO (Chief Legal Officer) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $246,148.
- KAREN FIRESTONE purchased 8,100 shares for an estimated $100,845
- CAMILLE L BEDROSIAN (Chief Medical Officer) sold 6,580 shares for an estimated $94,418
- JOSHUA B COHEN (Co-Chief Executive Officer) sold 7,715 shares for an estimated $85,596
- JUSTIN B. KLEE (Co-Chief Executive Officer) sold 7,715 shares for an estimated $85,589
- JAMES M FRATES (Chief Financial Officer) sold 3,326 shares for an estimated $36,953
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$AMLX Hedge Fund Activity
We have seen 98 institutional investors add shares of $AMLX stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 8,331,188 shares (+273.3%) to their portfolio in Q3 2025, for an estimated $113,220,844
- COMMODORE CAPITAL LP added 4,075,478 shares (+inf%) to their portfolio in Q3 2025, for an estimated $55,385,746
- FIRST LIGHT ASSET MANAGEMENT, LLC added 3,355,882 shares (+inf%) to their portfolio in Q3 2025, for an estimated $45,606,436
- JANUS HENDERSON GROUP PLC added 2,536,233 shares (+inf%) to their portfolio in Q3 2025, for an estimated $34,467,406
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 1,998,721 shares (-68.1%) from their portfolio in Q3 2025, for an estimated $27,162,618
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,983,172 shares (-22.5%) from their portfolio in Q3 2025, for an estimated $26,951,307
- PARADIGM BIOCAPITAL ADVISORS LP added 1,900,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $25,821,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$AMLX Analyst Ratings
Wall Street analysts have issued reports on $AMLX in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/07/2025
- Goldman Sachs issued a "Buy" rating on 09/16/2025
- Guggenheim issued a "Buy" rating on 09/15/2025
- B of A Securities issued a "Buy" rating on 08/28/2025
To track analyst ratings and price targets for $AMLX, check out Quiver Quantitative's $AMLX forecast page.
$AMLX Price Targets
Multiple analysts have issued price targets for $AMLX recently. We have seen 6 analysts offer price targets for $AMLX in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Andrew Fein from HC Wainwright & Co. set a target price of $20.0 on 11/07/2025
- Geoff Meacham from Citigroup set a target price of $20.0 on 10/17/2025
- Joel Beatty from Baird set a target price of $19.0 on 10/16/2025
- Geoff Meacham from B of A Securities set a target price of $16.0 on 10/03/2025
- Corinne Johnson from Goldman Sachs set a target price of $20.0 on 09/16/2025
- Seamus Fernandez from Guggenheim set a target price of $25.0 on 09/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
